0001209191-22-059756.txt : 20221205
0001209191-22-059756.hdr.sgml : 20221205
20221205171046
ACCESSION NUMBER: 0001209191-22-059756
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221130
FILED AS OF DATE: 20221205
DATE AS OF CHANGE: 20221205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FALBERG KATHRYN E
CENTRAL INDEX KEY: 0001206977
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 221445798
MAIL ADDRESS:
STREET 1: C/O AXOVANT SCIENCES, INC.
STREET 2: 320 WEST 37TH STREET, 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvation Bio Inc.
CENTRAL INDEX KEY: 0001811063
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850862255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 754-3517
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: Panacea Acquisition Corp
DATE OF NAME CHANGE: 20200430
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-30
0
0001811063
Nuvation Bio Inc.
NUVB
0001206977
FALBERG KATHRYN E
C/O NUVATION BIO INC.
1500 BROADWAY, SUITE 1401
NEW YORK
NY
10036
1
0
0
0
Class A Common Stock
2022-11-30
4
P
0
75041
1.8535
A
75041
I
By Trust
Class A Common Stock
2022-12-01
4
P
0
84959
1.9727
A
160000
I
By Trust
Class A Common Stock
2022-12-02
4
P
0
47000
1.9827
A
207000
I
By Trust
Class A Common Stock
2022-12-05
4
P
0
43000
1.9526
A
250000
I
By Trust
Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.805 to $1.90. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Shares are held directly by The Falberg-Predovich Family Trust, of which the Reporting Person is Co-Trustee.
Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.92 to $1.99. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.925 to $2.00. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Kathryn E. Falberg, by /s/ Ron A. Metzger, Attorney-in-Fact
2022-12-05